Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour
Abhenil Mittal1, Aarushi Gupta2, Sameer Rastogi1, Adarsh Barwad3 and Swati Sharma2
ecancer 15 1213 (2021) https://doi.org/10.3332/ecancer.2021.1213
1Department of Medical Oncology, Dr Bhim Rao Ambedkar (BRA) Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
2Department of Radiodiagnosis, ABVIMS and Dr RML Hospital, New Delhi 110001, India
3Department of Pathology, All India Institute of Medical Sciences, New Delhi 110029, India
Keywords: ceritinib, infant, inflammatory myofibroblastic tumour, low dose
Correspondence to: Sameer Rastogi
Publication costs for this article were supported by ecancer (UK Charity number 1176307).
Copyright: © the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The images published in this article were previously used by the authors in the article: Gupta A, Sharma S, and Mittal A et al (2021) Recurrent infantile inflammatory myofibroblastic tumor of mesentery—case report and review of imaging findings Radiol Case Rep 16(3) 504–510 [doi:10.1016/j.radcr.2020.12.027].
The authors have copyright of the images; however, this was not referenced.